Effect of Glucagon‐Like Peptide 1 Receptor Agonists on Patients With Rheumatoid Arthritis

Documenti analoghi

• Immunosuppressive Medications and Nonserious Infections in People With Rheumatoid Arthritis: A Prospective Cohort Study
  di: Michael D. George, et al.
  Pubblicazione: (2026)
• Characterization of Second‐Line Therapy After First JAK Inhibitor Use: Results From the CorEvitas Rheumatoid Arthritis Registry
  di: Joshua F. Baker, et al.
  Pubblicazione: (2025)
• Circulating Adipokines and Response to Treatment in Patients With Early Rheumatoid Arthritis
  di: Georgios K. Vasileiadis, et al.
  Pubblicazione: (2024)
• Clinical Course of Interstitial Lung Disease in Patients With Rheumatoid Arthritis
  di: Eric L. Matteson, et al.
  Pubblicazione: (2024)
• Similar Pain Scores in Rheumatoid Arthritis and Osteoarthritis Over 45 Years Despite Dramatically Fewer Swollen Joints in Rheumatoid Arthritis: Are Scores Based as Much on Pain Sensitization and Patient Distress as on Inflammation and/or Structural Damage?
  di: Juan Schmukler, et al.
  Pubblicazione: (2026)